MedPath

PET probe guided extirpation of FDG-PET positive lymph nodes which are negative on other imaging modalities in head and neck cancer patients scheduled for primary irradiatio

Completed
Conditions
head and neck cancer
head and neck squamous cell carcinoma
10038666
Registration Number
NL-OMON34841
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

• Patients with a primary biopsy proven head and neck cancer scheduled for primary irradiation with or without chemotherapy
• Lymph nodes which are positive on FDG-PET but negative on other imaging modalities
• Ultrasound guided fine needle aspiration cytology of these FDG-PET positive lymph nodes remains negative if performed after the results. This procedure must be performed afterwards if FDG-PET reveals these unexpected FDG-PET positive lymph nodes.
• FDG-PET positive lymph nodes have impact on radiation treatment planning if based on FDG-PET as judged by the radiation oncologist.
• *Informed consent* signed by patient

Exclusion Criteria

none

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Feasibility to extirpate these FDG-PET lymph nodes.<br /><br></p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Diagnostic accuracy of PET-CT in these by other imaging techniques negative<br /><br>lymph nodes.<br /><br>Chance of radiation planning.</p><br>
© Copyright 2025. All Rights Reserved by MedPath